Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 12
2006 11
2007 11
2008 12
2009 9
2010 8
2011 23
2012 17
2013 14
2014 23
2015 23
2016 30
2017 19
2018 29
2019 24
2020 23
2021 26
2022 33
2023 15
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Kim, Young-Gun; Jeon, Ja Young; Kim, Hae Jin; Kim, Dae Jung; Lee, Kwan-Woo; Moon, So Young; Han, Seung Jin. Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors versus Sulfonylureas: A Real-World Population-Based Cohort Study. Journal of Clinical Medicine 2019, 8, 28.
Kim YG, Jeon JY, Kim HJ, Kim DJ, Lee KW, Moon SY, Han SJ. Kim YG, et al. Among authors: kim dj. J Clin Med. 2019 Mar 20;8(3):389. doi: 10.3390/jcm8030389. J Clin Med. 2019. PMID: 30897780 Free PMC article.
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.
Kosiborod M, Lam CSP, Kohsaka S, Kim DJ, Karasik A, Shaw J, Tangri N, Goh SY, Thuresson M, Chen H, Surmont F, Hammar N, Fenici P; CVD-REAL Investigators and Study Group. Kosiborod M, et al. Among authors: kim dj. J Am Coll Cardiol. 2018 Jun 12;71(23):2628-2639. doi: 10.1016/j.jacc.2018.03.009. Epub 2018 Mar 11. J Am Coll Cardiol. 2018. PMID: 29540325 Free article. Clinical Trial.
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G, Fazeli Farsani S, Patorno E, Núñez J; EMPRISE Europe and Asia Study Group. Karasik A, et al. Among authors: kim dj. Diabetes Metab. 2023 Mar;49(2):101418. doi: 10.1016/j.diabet.2022.101418. Epub 2023 Jan 3. Diabetes Metab. 2023. PMID: 36608816 Free article.
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Kim NH, Seo JA, Kim MK, Lim JH, Song Y, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Choi WS, Moon MK. Choi JH, et al. Among authors: kim dj. Diabetes Metab J. 2023 Sep;47(5):575-594. doi: 10.4093/dmj.2023.0282. Epub 2023 Sep 26. Diabetes Metab J. 2023. PMID: 37793979 Free PMC article. Review.
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K; EMPRISE EU; East Asia Study Group. Vistisen D, et al. Among authors: kim dj. Cardiovasc Diabetol. 2023 Aug 31;22(1):233. doi: 10.1186/s12933-023-01963-9. Cardiovasc Diabetol. 2023. PMID: 37653496 Free PMC article.
How to Establish Clinical Prediction Models.
Lee YH, Bang H, Kim DJ. Lee YH, et al. Among authors: kim dj. Endocrinol Metab (Seoul). 2016 Mar;31(1):38-44. doi: 10.3803/EnM.2016.31.1.38. Endocrinol Metab (Seoul). 2016. PMID: 26996421 Free PMC article. Review.
Vitamin D and coronary atherosclerosis.
Kim DJ. Kim DJ. Osteoporos Sarcopenia. 2017 Dec;3(4):201. doi: 10.1016/j.afos.2017.11.003. Epub 2017 Nov 27. Osteoporos Sarcopenia. 2017. PMID: 30775531 Free PMC article. No abstract available.
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study.
Kim DJ, Sheu WH, Chung WJ, Yabe D, Ha KH, Nangaku M, Tan EC, Node K, Yasui A, Lei W, Lee S, Saarelainen L, Deruaz-Luyet A, Kyaw MH, Seino Y; EMPRISE East Asia Study Group. Kim DJ, et al. J Diabetes Investig. 2023 Mar;14(3):417-428. doi: 10.1111/jdi.13959. Epub 2023 Jan 30. J Diabetes Investig. 2023. PMID: 36716212 Free PMC article.
Epidemiology of Childhood Obesity in Korea.
Ha KH, Kim DJ. Ha KH, et al. Among authors: kim dj. Endocrinol Metab (Seoul). 2016 Dec;31(4):510-518. doi: 10.3803/EnM.2016.31.4.510. Epub 2016 Nov 3. Endocrinol Metab (Seoul). 2016. PMID: 27834078 Free PMC article. Review.
Trends in the Diabetes Epidemic in Korea.
Ha KH, Kim DJ. Ha KH, et al. Among authors: kim dj. Endocrinol Metab (Seoul). 2015 Jun;30(2):142-6. doi: 10.3803/EnM.2015.30.2.142. Epub 2015 May 18. Endocrinol Metab (Seoul). 2015. PMID: 26194073 Free PMC article. Review.
322 results